Abstract:
The invention relates to methods to select animals, such as mammals, in particularly domestic animals such as breeding animals or animals destined for slaughter for having desired genotypic or potential phenotypic properties, in particular related to muscle mass and/or fat deposition or, in the case of mammals, to teat number. The invention provides a method for selecting an animal for having desired genotypic or potential phenotypic properties comprising testing said animal, a parent of said animal or its progeny for the presence of a nucleic acid modification affecting the activity of an evolutionary conserved CpG island, located in intron 3 of an IGF2 gene and/or for the presence of a nucleic acid modification affecting binding of a nuclear factor to an IGF2 gene.
Abstract:
The invention relates to the field of biochemistry, molecular biology and microbiology. More specific the invention relates to methods and means for metabolic engineering and improved product formation by a filamentous micro-organism or a low G+C gram-positive bacterium. The invention discloses that DasR and DasR binding sites play an important and universal role in the control of gene expression in micro-organisms Based on this finding, the invention provides multiple useful applications, such as a method for regulating the expression of a gene of interest, a method for controlling metabolism, a method for decreasing undesired expression and many more. Moreover, the invention also provides means that can be used to establish said methods: for example a micro-organism in which the DasR binding site in operable linkage with a particular gene has been modified to obtain increased or decreased expression of a protein (being a desired or undesired protein) encoded by said gene.
Abstract:
The present invention relates to compositions for the treatment or prevention of Zoster of individuals infected with Varicella Zoster virus (VZV), and to the prevention and treatment of Varicella infections. The compositions of the invention comprise the protein encoded by VZV gene 63 or an immunologically active derivative thereof. The invention further relates to compositions containing DNA or RNA corresponding to VZV gene 63.
Abstract:
The invention relates to a method for preparing a biodegradable polyester foam involving: mixing polyester in the form of a molten mass with a nanocharge consisting of organomodified clay; dispersing the latter in the polyester molten mass, and; expanding this polyester foam obtained in such a manner in the presence of an expanding agent whereby forming the polyester foam having a homogeneous structure thanks to the addition of a siliconized surfactant to the molten mass.
Abstract:
New Pyrimidinetrione derivatives represented by formula I
wherein R1 and R2 are defined in the description, composition thereof, and methods of preparation are described. The compounds are useful in the treatment of disease involving metalloproteinases
Abstract:
This invention is related to a method for detecting toxic and non-toxic cyanobacteria. The method comprises that nucleic acid from a biological sample is brought into contact with an oligonucleotide designed to be specific for particular regions of the mcyE gene, the mcyE in combination with mcyD, and with an oligonucleotide designed to be specific for 16SrDNA, and the presence or absence of toxic cyanobacteria is detected by a suitable molecular biology method. The invention is related also to oligonucleotides used in the method.
Abstract:
New pyridinic sulfonamide derivatives represented by a general formula (I), wherein R1, represents a mono- or polyhalogenated Cl-12-alkyl or a mono- or poly-halogenated C3-8-cycloalkyl group. The method of production of such derivatives and their use as active therapeutic substance in the treatment of diseases such as inflammation, arthrosis, cancer, angiogenesis and asthma are also reported.
Abstract:
Association et procédé de préparation à base de cyprotérone et/ou d'un ester de celle-ci hydrosoluble, comprenant le mélange de cyprotérone et/ou d'ester de celle-ci avec au moins une cyclodextrine choisie dans le groupe : béta-cyclodextrine et ses dérivés, la gamma-cyclodextrine et ses dérivés et leurs mélanges. Composition pharmaceutique comprenant cette association et ayant une activité antiandrogénique et/ou progestative ou Composition pharmaceutique ayant une activité antiséborrhéique et/ou antialopécique. Enfin, utilisation de cette association à base de cyprotérone et/ou d'un ester en combinaison ou non avec un oestrogène, dans la préparation d'un médicament pour le traitement de l'hyperandrogénie, de l'hirsutisme, de l'acné sévère et des troubles liés à la ménopause . Utilisation de cette association dans la préparation d'un médicament dans le traitement de la séborrhée et/ou de l'alopécie androgénique.
Abstract:
A monomode optical fibre provided for transporting light having a wavelength λ with 480 ≤ λ ≤ 550 nm, said fibre comprising a core made of a first transparent dielectric material, having a first refractive index n c and a substantially circular cross-section with a radius dimension a, said fibre further comprising a first cladding coaxially applied on said core and made of a second transparent dielectric material having a second refractive index n m1 , wherein n m1 c , The values of n c and n m1 are chosen in such a manner that the numerical aperture is less than 0.1 and wherein said radius dimension a > 2 µm.
Abstract:
The invention relates to methods to select breeding animals or animals destined for slaughter for having desired genotypic or potential phenotypic properties, in particular related to muscle mass and/or fat deposition. The invention provides a method for selecting a pig for having desired genotypic or potential phenotypic properties comprising testing a sample from said pig for the presence of a quantitative trait locus (QTL) located at a Sus scrofa chromosome 2 mapping at position 2p1.7.